81.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$80.67
Aprire:
$80.73
Volume 24 ore:
2.28M
Relative Volume:
0.30
Capitalizzazione di mercato:
$103.27B
Reddito:
$386.46B
Utile/perdita netta:
$4.49B
Rapporto P/E:
22.70
EPS:
3.5841
Flusso di cassa netto:
$4.78B
1 W Prestazione:
+5.80%
1M Prestazione:
+10.49%
6M Prestazione:
+18.44%
1 anno Prestazione:
+24.87%
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CVS
Cvs Health Corp
|
81.42 | 101.03B | 386.46B | 4.49B | 4.78B | 3.5841 |
![]()
UNH
Unitedhealth Group Inc
|
357.78 | 325.98B | 422.82B | 22.09B | 25.27B | 23.09 |
![]()
ELV
Elevance Health Inc
|
349.59 | 78.92B | 189.25B | 5.35B | 5.34B | 23.49 |
![]()
CI
Cigna Group
|
292.51 | 80.65B | 261.22B | 5.40B | 3.94B | 18.31 |
![]()
HUM
Humana Inc
|
264.84 | 31.46B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
2024-05-30 | Iniziato | Robert W. Baird | Neutral |
2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
2024-05-02 | Downgrade | UBS | Buy → Neutral |
2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
2024-03-06 | Iniziato | Barclays | Equal Weight |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2023-12-22 | Iniziato | HSBC Securities | Buy |
2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
2023-05-26 | Iniziato | Piper Sandler | Overweight |
2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
2022-11-23 | Ripresa | Morgan Stanley | Overweight |
2022-06-17 | Iniziato | Loop Capital | Buy |
2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
2021-12-14 | Iniziato | Goldman | Buy |
2021-12-01 | Iniziato | Seaport Research Partners | Buy |
2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
2020-09-17 | Iniziato | Piper Sandler | Overweight |
2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
2019-09-12 | Iniziato | Deutsche Bank | Buy |
2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
2019-04-18 | Iniziato | Guggenheim | Buy |
2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
2019-04-10 | Reiterato | BofA/Merrill | Buy |
2019-03-13 | Iniziato | Bernstein | Outperform |
2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
2019-01-17 | Iniziato | UBS | Buy |
2018-12-18 | Iniziato | Barclays | Overweight |
2018-11-29 | Ripresa | Goldman | Neutral |
2018-11-28 | Iniziato | Evercore ISI | Outperform |
2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
2018-02-27 | Ripresa | BofA/Merrill | Buy |
2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
CVS takes over Rite Aid assets in bankruptcy deal - Yahoo
CVS polishes off deal to buy former Rite Aid stores, prescription files - Hartford Courant
Shoppers trust pharmacists and want one-on-one care: report - Supermarket News
CVS finalises purchase of Rite Aid stores and assets - Yahoo Finance
CVS is closing hundreds of stores nationwide: Here’s where - AOL.com
The Pharmacy Stock That's Cheaper Than It Should Be - AOL.com
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
CVS completes acquisition of 63 Rite Aid stores, 626 prescription files - Investing.com
CVS Acquires Rite Aid Assets to Expand Nationwide Presence - GuruFocus
CVS Health price target raised to $89 from $82 at Morgan Stanley - Yahoo Finance
63 former Rite Aid & Bartell stores: CVS completes acquisition, now serving more than 9 million former patients - Stock Titan
CVS Health EVP Capozzi buys shares worth $4588 By Investing.com - Investing.com South Africa
Ambulatory Infusion Center Market Growth Driven by Rising - openPR.com
CVS Health EVP Capozzi buys shares worth $4588 - Investing.com
How to build a custom watchlist for CVS Health CorporationJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
CVS Health (CVS) Sees Analyst Raise Price Target to $89 | CVS St - GuruFocus
Goldman Sachs Initiates Coverage on CVS Health with a Buy Rating | CVS Stock News - GuruFocus
Jim Cramer Admits He Was Wrong About CVS Health’s (CVS) Aetna - Yahoo Finance
77% of adults trust pharmacists — CVS Health 2025 Rx Report: 80% prefer in-person care; tech aids teams - Stock Titan
CVS Health Corporation $CVS Shares Sold by Community Bank N.A. - MarketBeat
Why CVS Health Corporation is moving todayMarket Trend Report & Verified Stock Trade Ideas - newser.com
CVS Health (NYSE:CVS) Hits New 52-Week HighShould You Buy? - MarketBeat
Recent Cases Spotlight Retention Lessons for AI Content from Video Recordings - JD Supra
Cvs Health Corp stock hits 52-week high at 79.21 USD - Investing.com Canada
Is now a turning point for CVS Health CorporationCEO Change & Short-Term High Return Ideas - newser.com
CVS Launches Workforce Innovation and Talent Center and Community Resource Center in Fort Worth - Yahoo Finance
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock? - Yahoo Finance
Concord Asset Management LLC VA Buys Shares of 34,078 CVS Health Corporation $CVS - MarketBeat
Yousif Capital Management LLC Has $15.60 Million Stake in CVS Health Corporation $CVS - MarketBeat
Pzena Investment Management LLC Sells 935,521 Shares of CVS Health Corporation $CVS - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 21,544 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Tops US Medicare Quality Ratings For 2026 - Finimize
Is CVS Health Corporation stock in correction or buying zoneJuly 2025 Spike Watch & Accurate Buy Signal Alerts - newser.com
Using Bollinger Bands to evaluate CVS Health Corporation2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Rep. Val T. Hoyle Sells CVS Health Corporation (NYSE:CVS) Shares - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Means Investment CO. Inc. - MarketBeat
GFS Advisors LLC Has $248,000 Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Aberdeen Group plc - MarketBeat
US Bancorp DE Lowers Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Thompson Investment Management Inc. - MarketBeat
Mengis Capital Management Inc. Decreases Position in CVS Health Corporation $CVS - MarketBeat
Commerzbank Aktiengesellschaft FI Purchases 10,795 Shares of CVS Health Corporation $CVS - MarketBeat
Coerente Capital Management Reduces Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Venturi Wealth Management LLC Takes $259,000 Position in CVS Health Corporation $CVS - MarketBeat
Belpointe Asset Management LLC Trims Stake in CVS Health Corporation $CVS - MarketBeat
3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026 - The Motley Fool
How Recent Developments Are Rewriting the Story for CVS Health - Yahoo Finance
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Why CVS Health Corporation (CVS) stock appeals to dividend investorsWeekly Volume Report & Daily Price Action Insights - newser.com
CVS Health (NYSE:CVS) Given New $88.00 Price Target at Mizuho - MarketBeat
CVS Health Leads In Top-Rated Medicare Plans, Edging Out Rivals - Finimize
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):